PBYI Stock Ownership Activity

PUMA BIOTECHNOLOGY INC 13F holders

1 value investing guru has made changes to the PUMA BIOTECHNOLOGY INC (PBYI) position according to the gurus' latest SEC quarterly report(s). PBYI has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds are buying PBYI now?

According to the latest SEC filing(s) PUMA BIOTECHNOLOGY INC (PBYI) has been bought by Sarah Ketterer - Causeway Capital Management (new buy).

To see more about who is investing in PUMA BIOTECHNOLOGY INC (PBYI), please go to the PBYI ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2025 Q1 (1 result)
Sarah Ketterer
Causeway Capital Management
buy
+14,095
+0.00%
0.00%
Current price: $3.28 10.81% Reported price*: $2.96
2018 Q4 (1 result)
Glenn W. Welling
Engaged Capital
-100.00%
-151,689
-1.29%
0.00%
Current price: $3.28 92.85% Reported price*: $45.85
2018 Q3 (1 result)
Glenn W. Welling
Engaged Capital
buy
+151,689
+0.98%
0.00%
Current price: $3.28 92.85% Reported price*: $45.85
3 of 3

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.